1. Home
  2. CDIO vs YDKG Comparison

CDIO vs YDKG Comparison

Compare CDIO & YDKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardio Diagnostics Holdings Inc.

CDIO

Cardio Diagnostics Holdings Inc.

HOLD

Current Price

$2.60

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Yueda Digital Holding Class A Ordinary Share

YDKG

Yueda Digital Holding Class A Ordinary Share

N/A

Current Price

$0.86

Market Cap

4.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
CDIO
YDKG
Founded
2017
2005
Country
United States
China
Employees
9
17
Industry
Biotechnology: Commercial Physical & Biological Resarch
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
4.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CDIO
YDKG
Price
$2.60
$0.86
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.6M
66.4K
Earning Date
03-13-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$171,906.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.02
52 Week High
$7.91
$3.90

Technical Indicators

Market Signals
Indicator
CDIO
YDKG
Relative Strength Index (RSI) 41.73 50.55
Support Level $1.26 $0.81
Resistance Level $4.24 $0.94
Average True Range (ATR) 0.82 0.06
MACD -0.39 0.00
Stochastic Oscillator 9.18 33.82

Price Performance

Historical Comparison
CDIO
YDKG

About CDIO Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About YDKG Yueda Digital Holding Class A Ordinary Share

Yueda Digital Holding is a digital-economy company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.

Share on Social Networks: